• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

PHA 568487

CAS No. 527680-56-4

PHA 568487 ( —— )

产品货号. M24500 CAS No. 527680-56-4

奎宁环 PHA 568487 是 α7 烟碱乙酰胆碱受体的激动剂,旨在减轻与核心支架相关的生物活化,并随后消除与体内耐受性相关的负债。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
2MG ¥150 有现货
5MG ¥367 有现货
10MG ¥651 有现货
25MG ¥1144 有现货
50MG ¥1693 有现货
100MG ¥2331 有现货
200MG ¥3123 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    PHA 568487
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    奎宁环 PHA 568487 是 α7 烟碱乙酰胆碱受体的激动剂,旨在减轻与核心支架相关的生物活化,并随后消除与体内耐受性相关的负债。
  • 产品描述
    The quinuclidine PHA 568487 is an agonist of the alpha 7 nicotinic acetylcholine receptor that was designed to mitigate the bioactivation associated with the core scaffold and subsequently remove associated liabilities with in vivo tolerability.
  • 体外实验
    PHA 568487, α-7 nAchR-specific agonist, prevents NF-κb activation in the cells.PHA 568487 treatment significantly reduces the expression of leukocyte infiltration molecules in MCAO rats and in endothelial cells after in vitro ischemia.
  • 体内实验
    PHA 568487 treatment reduces mouse cognitive decline caused by aseptic bone fracture by promoting inflammation resolution. PHA 568487 (PHA; 0.8 mg/kg; injected intraperitoneally) reduces infarct volume and TUNEL positive neurons in the peri-infarct regions of permanent middle cerebral artery occlusion (pMCAO) and pMCAO+tibia fracture mice.The role played by a7 receptors on neuroinflammation is supported by the decrease of [18F]DPA-714 binding in ischemic rats treated with the a7 agonist PHA 568487 at day 7 after MCAO. PHA 568487-treated ischemic rats show a significant reduction of the cerebral infarct volumes and an improvement of the neurologic outcome compared with non-treated MCAO rats. Animal Model:C57BL/6J male mice (10-12 weeks old) with pMCAO Dosage:0.4 and 0.8 mg/kg Administration:Injected intraperitoneally once on day 1, or twice on days 1 and 2, after pMCAO Result:0.8 mg/kg on days 1 and 2 after pMCAO yielded the best effect on infarct volume and behavior tests.Animal Model:Adult male Sprague-Dawley rats Dosage:1.25 mg/kg Administration:Treated i.p. daily with 0.1 mL Result:Showed a significant decrease of [18F]DPA-714 binding in the ischemic cerebral hemisphere in comparison to non-treated ischemic rats.
  • 同义词
    ——
  • 通路
    Endocrinology/Hormones
  • 靶点
    AChR
  • 受体
    α7 nicotinic acetylcholine receptor
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    527680-56-4
  • 分子量
    288.34
  • 分子式
    C16H20N2O3
  • 纯度
    >98% (HPLC)
  • 溶解度
    H2O:<40.44mg/ml (100mM); DMSO:<40.44mg/ml (100mM)
  • SMILES
    O=C(c(cc1)cc2c1OCCO2)N[C@@H]1C(CC2)CCN2C1
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1.Shilliday F, et al. Multiple species metabolism of PHA-568487, a selective alpha 7 nicotinic acetylcholine receptor agonist. Drug Metab Lett. 2010 Aug;4(3):162-72.
产品手册
关联产品
  • Benzetimide hydrochl...

    Benzetimide Hydrochloride 是毒蕈碱乙酰胆碱受体的拮抗剂。治疗抗精神病药引起的帕金森病。

  • Decamethonium bromid...

    Decamethium Bromide 是一种烟碱型 AChR 部分激动剂和神经肌肉阻滞剂。

  • Dichlorisone Acetate

    属于有机磷酸酯类化合物,是一种常用的环境卫生杀虫剂。